NEWS COMMENTARY

Point-of-care diagnostic that diagnoses COVID-19 in under an hour in development at UCSD

Published:
March 18, 2020
Coverage:
Digital Transformation More...
Activities:
Research
by Nardev Ramanathan
Very important

The evolving COVID-19 pandemic is in dire need of rapid actionable tests to mitigate the widespread infection it is causing. While efforts are in full swing across the globe to develop vaccines and scale up production of conventional diagnostic kits, a pressing need right now is to quickly identify and isolate patients to prioritize medical assistance. The fastest diagnostics still take a few hours at best. Researchers at UCSD are working to address this need with a test that can identify a suspected COVID-19 case in 45 minutes, meeting the criteria for a POCD outlined in our recent report. In these trying times, as clients look to invest in or partner with developers, POCD solutions like this must make your shortlist for further vetting.

For the original news article, click here .


Further Reading

U.S. FDA gives marketing authorization for first point-of-care diagnostic test for Ebola virus

News Commentary | October 15, 2019

Ebola is one of the deadliest infectious diseases known to man. While confined to rural parts of Africa, an Ebola outbreak can have global consequences. In the year 2014 alone, Ebola outbreaks were reported in the U.S., Spain, and the U.K. Rapid detection and intervention, however, can save lives. ... To read more, click here.

British scientists develop diagnostic test that detects urinary tract infection (UTI) in under 30 minutes

News Commentary | January 09, 2020

We've highlighted how point‑of‑care diagnostics (POCD) for acute conditions like infectious diseases must improve on speed to result, ease of use, reliability, and cost to be relevant. This is one such use case. The portable device uses small capillaries that trap E. coli bacteria (present in most ... Not part of subscription

Everlywell to roll out home testing kits for COVID-19

News Commentary | March 19, 2020

Everlywell has developed a kit for COVID‑19 and will launch on March 23, 2020. This is extremely important because it allows the scientific community to get the numbers needed to effectively plan response strategies for the next 18 months – the expected timeline for vaccine distribution. Right now, ... To read more, click here.